20-321 - Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer
Status: openA Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer
Patients with Pancreatic Cancer
Contact Us
If you have questions about this trial or are interested in participating, please contact Wendy Blount, director of clinical trials, at (251) 445-9834 or wlblount@health.southalabama.edu.
Description
This study will compare the usual treatment approach in treating pancreatic cancer (surgery followed by chemotherapy) to using chemotherapy before and after surgery. This study will help the study doctors find out if this different approach is better, the same, or worse than the usual approach. To decide if it is better, the study doctors will be looking to see if the study approach increases the life of patients compared to the usual approach.
Sponsors
This trial is sponsored by National Cancer Institute (NCI).Providers Associated With This Trial
![Annabelle L. Fonseca, M.D., M.H.S.]()
View ProfileAnnabelle L. Fonseca, M.D., M.H.S.Surgical OncologistAssistant Professor of SurgerySurgical Oncology ClinicView All Locations
Sub Investigators
![Persing brian]()
View ProfileBrian E. Persing, M.D.Medical Oncologist and HematologistAssistant Professor of Interdisciplinary Clinical Oncology
